Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 12, 2023, titled "CEQUA showed sustained improvement in dry eye disease patients switched from Restasis".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 12, 2023, titled "CEQUA showed sustained improvement in dry eye disease patients switched from Restasis".